等待開盤 07-18 09:30:00 美东时间
+0.070
+87.50%
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 33.76 percent. This is a 61.54 percent decrease over losses of $(0.13) per share
07-15 06:32
HC Wainwright & Co. analyst Yi Chen maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and lowers the price target from $7 to $5.
07-01 19:40
New patents received for the treatment of epilepsy and for the sublingual delivery of nicotineKELOWNA, BC / ACCESS Newswire / June 23, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or
06-23 21:18
Lexaria Bioscience ( ($LEXX) ) just unveiled an announcement. Lexaria Bioscienc...
06-11 22:39
Lexaria Bioscience ( ($LEXX) ) just unveiled an update. Lexaria Bioscience Corp...
05-12 23:46
An announcement from Lexaria Bioscience ( ($LEXX) ) is now available. Lexaria B...
04-03 23:08
Lexaria Bioscience ( ($LEXX) ) has provided an announcement. Lexaria Bioscience...
03-18 23:08
The latest announcement is out from Lexaria Bioscience ( ($LEXX) ). Lexaria Bio...
02-21 00:39
Lexaria Bioscience ( ($LEXX) ) has shared an announcement. Lexaria Bioscience C...
02-07 00:45